3 Matching Annotations
  1. Last 7 days
  2. aacrjournals.org aacrjournals.org
    PI3Kα inhibitor and degrader inavolisib can co-opt FGFR2 to enhance responses in patients with PIK3CA-mutated solid tumors and in preclinical models
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/clincancerres/article/32/1/56/771272/PI3K-Inhibitor-and-Degrader-Inavolisib-Can-Co-opt
  3. Jun 2023
  4. 52.53.155.43 52.53.155.43
    Discovery of a Selective and Orally Bioavailable FGFR2 Degrader for Treating Gastric Cancer
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/26aa5ba62138ec506c6f952066d20d6f92d1221c/acs.jmedchem.3c00150-html.html
  5. Jul 2021
  6. www.sciencedirect.com www.sciencedirect.com
    ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S221112472100872X